비비나비 : 세계 : () World

Centers for Medicare & Medicaid ServicesAnnouncement: Inflation Reduction Act and Medicare.

November 26, 2024

*Revised Information Collection Request (ICR) for* *Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027*

The Negotiation Data Elements and Drug Price Negotiation Process revised ICR can be found in the Federal Register [ https://www.federalregister.gov/documents/2024/11/25/2024-27490/agency-information-collection-activities-submission-for-omb-review-comment-request ]. The full text of the ICR can also be found at CMS' PRA website [ https://www.cms.gov/regulations-and-guidance/legislation/paperworkreductionactof1995/pra-listing/cms-10849 ].  This ICR includes the data and information the federal government will collect for consideration when negotiating maximum fair prices, as well as the data and information to be submitted in the offer and counteroffer negotiation process. The ICR is open for public input for 30 days. Comments are due by December 26, 2024.

*Contract Year 2026 Medicare Advantage (MA) and Part D Proposed Rule *

On November 26, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would revise the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (PACE). The proposed rule includes several proposals related to the Inflation Reduction Act (IRA) including the Medicare Prescription Payment Plan, Part D improvements such as $35 covered insulin and $0 ACIP recommended vaccines, and operational requirements for maximum fair price effectuation.  Additional information can be found in the Press Release [ https://www.cms.gov/newsroom/press-releases/biden-harris-administration-announces-medicare-advantage-and-medicare-part-d-prescription-drug ] and Fact Sheet [ https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription ]. To review or comment on the CY 2026 MA and Part D proposed rule during its 60-day public comment period, visit the Federal Register [ https://www.federalregister.gov/public-inspection/2024-27939/medicare-and-medicaid-programs-contract-year-2026-policy-and-technical-changes-to-the-medicare ]. Comments must be submitted no later than January 27, 2025.

Blue abstract shape.


________________________________________________________________________

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].


________________________________________________________________________

This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244


body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}